10-Week Research Cycle

Συνδυασμός απόδοσης και αντοχής

Ερευνητικός συνδυασμός που έχει διερευνηθεί για βελτιώσεις σε δείκτες απόδοσης, αξιοποίηση VO2 και μυϊκή αντοχή σε υποκείμενα μελέτης.

Full stack price
968 € EUR822 € EUR
Εξοικονομήστε 146 € EUR · έκπτωση κιτ 15%
The Stack

What's in the stack

3 precision-matched compounds · 7 vials total for the 10-week cycle.

HGH3× συσκευασία 10 φιαλιδίων

3× HGH

10IU / φιαλίδιο · Λυοφιλιωμένη σκόνη

328 € EUR
110 € EUR / συσκευασία

Ανασυνδυασμένη ανθρώπινη αυξητική ορμόνη

Προβολή ένωσηςΛεπτομέρειες →
MOTS-c2× συσκευασία 10 φιαλιδίων

2× MOTS-c

10mg / φιαλίδιο · Λυοφιλιωμένη σκόνη

270 € EUR
136 € EUR / συσκευασία

Μεταβολικό πεπτίδιο μιτοχονδριακής προέλευσης

Προβολή ένωσηςΛεπτομέρειες →
CJC-1295 + Ipamorelin2× συσκευασία 10 φιαλιδίων

2× CJC-1295 + Ipamorelin

5mg + 5mg / φιαλίδιο · Λυοφιλιωμένη σκόνη

370 € EUR
186 € EUR / συσκευασία

Κλασικός συνδυασμός GHRH + μιμητικού γκρελίνης

Προβολή ένωσηςΛεπτομέρειες →
Research context

About the Συνδυασμός απόδοσης και αντοχής

The Performance & Endurance Stack pairs systemic growth-hormone signalling (HGH) with a mitochondrially-derived metabolic peptide (MOTS-c) and the most-studied GH secretagogue pairing in pre-clinical literature (CJC-1295 + Ipamorelin). The combination is designed for research applications investigating performance, endurance, and recovery-pathway modulation in athletic-research populations.

The 10-week cycle structure reflects the longer adaptation windows that performance and endurance research literature typically uses — shorter windows underestimate the steady-state effects of GH secretagogues, while longer windows risk confounding adaptation effects with the intervention itself.

All compounds are HPLC-verified to ≥99% purity, batch-traceable, and ship from Australian stock. The kit is supplied for laboratory research use only and is not represented for human therapeutic use.

Why these compounds together

Human growth hormone (HGH) provides systemic anabolic, recovery, and metabolic signalling — the foundational hormone whose pulsatile rhythm is the central focus of the broader research literature on GH-axis modulation. The protocol includes HGH as the systemic backbone of the stack.

CJC-1295 + Ipamorelin amplify endogenous GH release through complementary receptor pathways. CJC-1295 (a GHRH analogue) binds the GHRH receptor on pituitary somatotrophs; Ipamorelin (a selective ghrelin-receptor agonist) binds the growth-hormone secretagogue receptor. The two pathways are independent but synergistic — combining them produces a larger pulsatile GH response in research models than either compound alone, while leaving the natural pulsatile rhythm intact.

MOTS-c covers the mitochondrial side of the performance question. Mitochondrial output is the rate-limiting factor for sustained endurance work, and MOTS-c is studied as a putative AMPK pathway activator that supports mitochondrial fatty-acid oxidation and exercise capacity. The pairing of GH-axis signalling with mitochondrial-pathway support is designed to cover both anabolic and oxidative-output sides of the performance research question.

Cycle structure

The 10-week cycle aligns with common adaptation windows in performance and GH-axis research literature. Phase 1 (weeks 1-3) establishes baseline measurements and dose titration; phase 2 (weeks 4-8) covers the peak intervention window; phase 3 (weeks 9-10) covers taper and post-intervention measurement.

Researchers should reference primary literature for protocol-specific dosing — the kit is supplied as research materials, not as a fixed clinical regimen.

Synergy

Why these compounds together

Η HGH παρέχει συστηματική αναβολική σηματοδότηση και σηματοδότηση ανάκαμψης, το MOTS-c υποστηρίζει τη μιτοχονδριακή απόδοση και ο συνδυασμός CJC + Ipamorelin προκαλεί ενδογενείς παλμούς GH. Η έρευνα υποδεικνύει συνεργικές επιδράσεις σε δείκτες απόδοσης και αντοχής.

Designed for

Προχωρημένοι ερευνητές που προπονούνται σε υψηλό όγκο και ένταση.

Cycle

Research cycle structure

Week 1
Week 10
Phase 1
Ramp & establish baseline
Phase 2
Peak protocol window
Phase 3
Taper & recovery
Researcher FAQ

Συνδυασμός απόδοσης και αντοχής — frequently asked questions

What peptides are used for muscle growth research?

The most extensively studied compounds in muscle-growth research include human growth hormone (HGH), GHRH analogues (CJC-1295, Tesamorelin), GH secretagogues (Ipamorelin), and IGF-1 family peptides. Pairing of CJC-1295 with Ipamorelin is the most common combination in pre-clinical GH-axis research. The Quantum Labs Performance & Endurance Stack pairs HGH with the CJC + Ipamorelin combination plus MOTS-c for mitochondrial-pathway support.

What is the difference between HGH and GH secretagogues?

HGH provides direct exogenous growth-hormone signalling. GH secretagogues (CJC-1295, Ipamorelin, Tesamorelin) stimulate the pituitary to release endogenous GH in a more naturalistic pulsatile pattern. Research protocols often pair the two — exogenous HGH provides baseline coverage, secretagogues preserve pulsatile rhythm. The Performance Stack uses both.

Is the Performance Stack legal in Australia?

HGH is a prescription-only medicine (S4) in Australia. The Performance Stack is supplied for research and laboratory use only, not for human therapeutic supply. Researchers should ensure their use complies with applicable institutional and regulatory requirements. Quantum Labs supplies this stack for laboratory and pre-clinical research use only. It is not represented for human therapeutic use, and questions about clinical dosing or expected personal outcomes should be directed to a qualified medical practitioner.

What does the Performance & Endurance Stack kit contain?

3× HGH vials, 2× MOTS-c vials, 2× CJC-1295 + Ipamorelin vials — sized for the 10-week research cycle. All compounds lyophilised, sealed, HPLC-verified ≥99% purity, batch-traceable. Ships from Australian stock as a single kit.

Is PCT needed for the Performance Stack?

Post-cycle therapy is generally associated with research protocols that suppress the HPG axis (androgen-receptor agonists, SARMs, AAS). The Performance Stack focuses on the GH-IGF-1 axis rather than the HPG axis, so structured PCT is not part of the protocol design. Researchers should monitor the relevant biomarkers for their specific study question.

How long is a typical performance peptide research cycle?

GH-axis research cycles in published literature commonly run 8-16 weeks, with 10 weeks being a frequent middle ground. Shorter cycles underestimate steady-state effects; longer cycles risk confounding adaptation with the intervention. The Performance & Endurance Stack is sized for the 10-week window.

Μόνο για ερευνητική χρήση. Αυτή η ένωση πωλείται αυστηρά για έρευνα in vitro και εργαστηριακούς σκοπούς και δεν προορίζεται για ανθρώπινη κατανάλωση ή θεραπευτική χρήση. Με την αγορά επιβεβαιώνετε ότι είστε εξειδικευμένος ερευνητής και αποδέχεστε την πλήρη αποποίηση ευθύνης.

Begin Cycle

Ready to start this protocol?

All 7 vials sized for the 10-week cycle, plus the protocol guide PDF. Shipped worldwide.

Not sure? Take the 60-second quiz
Performance Peptide Stack Australia | GH Secretagogue Research | Quantum Labs